U.S. Physical Therapy (NYSE:USPH) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

USPH Panoramica delle azioni

U.S. Physical Therapy, Inc. gestisce cliniche di terapia fisica ambulatoriale.

USPH analisi fondamentale
Punteggio fiocco di neve
Valutazione	3/6
Crescita futura	3/6
Prestazioni passate	0/6
Salute finanziaria	4/6
Dividendi	3/6

Premi

Negoziato a 55.4% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 37.09% all'anno

Gli analisti concordano sul fatto che il prezzo delle azioni salirà di 35.8%

Analisi del rischio

Importanti vendite da parte di insider negli ultimi 3 mesi

Il dividendo di 2.1% non è ben coperto dagli utili

Grandi elementi una tantum che incidono sui risultati finanziari

I margini di profitto (2.6%) sono inferiori rispetto allo scorso anno (4.4%)

U.S. Physical Therapy, Inc. Concorrenti

National HealthCare

NYSEAM:NHC

US$2.0b

Ardent Health Partners

NYSE:ARDT

US$2.4b

Concentra Group Holdings Parent

NYSE:CON

US$3.0b

Select Medical Holdings

NYSE:SEM

US$4.4b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per U.S. Physical Therapy
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$82.50
Massimo di 52 settimane	US$113.63
Minimo di 52 settimane	US$78.08
Beta	1.38
1Variazione di 1 mese	-14.88%
Variazione a 3 mesi	-18.98%
Variazione di 1 anno	-17.87%
3Variazione a 3 anni	-26.60%
Variazione a 5 anni	-38.10%
Variazione dall'IPO	3,313.79%

Notizie e aggiornamenti recenti

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17

Recent updates

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Jun 04

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

May 21

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

May 11

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05

U.S. Physical Therapy: Not The Most Comfortable Prospect

Nov 09

U.S. Physical Therapy acquires physical therapy practice for $19.3M

Nov 01

U.S. Physical Therapy says Hurricane Ian affected about 50 clinics, ~$395K in lost sales

Oct 17

What Is U.S. Physical Therapy, Inc.'s (NYSE:USPH) Share Price Doing?

Oct 05

U.S. Physical Therapy acquires two-clinic practice

Oct 03

Rendimenti per gli azionisti

	USPH	US Healthcare	US Mercato
7D	-0.7%	0.9%	3.1%
1Y	-17.9%	12.7%	24.9%

Ritorno vs Industria: USPH ha avuto una performance inferiore rispetto al US Healthcare che ha registrato un rendimento 11.5 % nell'ultimo anno.

Rendimento vs Mercato: USPH ha avuto una performance inferiore al mercato US che ha registrato un rendimento 25.6 % nell'ultimo anno.

Volatilità dei prezzi

Is USPH's price volatile compared to industry and market?
USPH volatility
USPH Average Weekly Movement	4.7%
Healthcare Industry Average Movement	7.1%
Market Average Movement	6.3%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	3.2%

Prezzo delle azioni stabile: Il prezzo delle azioni di USPH è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di USPH è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1990	5,310	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. gestisce cliniche di terapia fisica ambulatoriale. L'azienda opera attraverso i segmenti Physical Therapy Operations e Industrial Injury Prevention Services. L'azienda fornisce cure e trattamenti pre e post operatori per disturbi ortopedici, infortuni sportivi, cure preventive, riabilitazione di lavoratori infortunati e infortuni neurologici.

U.S. Physical Therapy, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di U.S. Physical Therapy con la sua capitalizzazione di mercato?
USPH statistiche fondamentali
Capitalizzazione di mercato	US$1.25b
Guadagni(TTM)	US$15.88m
Ricavi(TTM)	US$621.23m

78.4x

Rapporto P/E

2.0x

Rapporto P/S

USPH è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
USPH Conto economico (TTM)
Ricavi	US$621.23m
Costo del fatturato	US$500.52m
Profitto lordo	US$120.71m
Altre spese	US$104.83m
Guadagni	US$15.88m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	1.05
Margine lordo	19.43%
Margine di profitto netto	2.56%
Rapporto debito/patrimonio netto	21.7%

Come si è comportato USPH nel lungo periodo?

Vedi performance storica e confronto

Dividendi

2.1%

Rendimento attuale del dividendo

165%

Rapporto di remunerazione

USPH paga dividendi affidabili?

Vedere la storia dei dividendi e i benchmark di USPH

Quando è necessario acquistare USPH per ricevere un dividendo imminente?
U.S. Physical Therapy date dei dividendi
Data di stacco del dividendo	Aug 23 2024
Data di pagamento dei dividendi	Sep 13 2024
Giorni fino al dividendo Ex	0 days
Giorni prima della data di pagamento dei dividendi	21 days

USPH paga dividendi affidabili?

Vedere la storia dei dividendi e i benchmark di USPH

USPH Panoramica delle azioni

Premi

Analisi del rischio

U.S. Physical Therapy, Inc. Concorrenti

NYSEAM:NHC

US$2.0b

NYSE:ARDT

US$2.4b

NYSE:CON

US$3.0b

NYSE:SEM

US$4.4b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Now 20% undervalued after recent price drop

Recent updates

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Chairman & CEO notifies of intention to sell stock

Chairman & CEO recently sold US$212k worth of stock

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

Chief Operating Officer - East recently sold US$261k worth of stock

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

First quarter dividend of US$0.44 announced

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Price target increased by 9.0% to US$119

Chief Operating Officer - West recently sold US$274k worth of stock

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.44 per share

Fourth quarter dividend increased to US$0.44

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Now 20% undervalued after recent price drop

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

Price target decreased by 7.9% to US$118

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Chief Operating Officer - West recently sold US$452k worth of stock

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Chief Operating Officer - West notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

Price target increased by 7.9% to US$119

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023